We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24.6B
AUM Growth
-$539M
(-2.1%)
Cap. Flow
-$2.74B
Cap. Flow
% of AUM
-11.15%
Top 10 Holdings %
Top 10 Hldgs %
16.61%
Holding
1,387
New
97
Increased
426
Reduced
465
Closed
225
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$66.4M |
| 2 |
Microsoft
MSFT
|
+$52.8M |
| 3 |
Mastercard
MA
|
+$39.5M |
| 4 |
Linde
LIN
|
+$28.7M |
| 5 |
Ferrari
RACE
|
+$27.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$160M |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$106M |
| 3 |
iShares Morningstar Growth ETF
ILCG
|
+$105M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$104M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.52% |
| 2 | Healthcare | 17.23% |
| 3 | Financials | 12.29% |
| 4 | Consumer Discretionary | 11.39% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Welltower
WELL
$168B
| $35.8M | 0.15% |
437,392
-10,227
| -2% | -$876K |
|
177
Snap-on
SNA
$19.4B
| $35.6M | 0.14% |
209,998
+84,300
| +67% | +$13.7M |
|
178
Royal Caribbean
RCL
$66.7B
| $35.5M | 0.14% |
266,163
-9,825
| -4% | -$1.15M |
|
179
Q2 Holdings
QTWO
$3.75B
| $35.3M | 0.14% |
435,057
-48,039
| -10% | -$3.69M |
|
180
Regeneron Pharmaceuticals
REGN
$79.6B
| $35.2M | 0.14% |
93,779
+45,751
| +95% | +$15.4M |
|
181
J.M. Smucker
SJM
$13B
| $34.8M | 0.14% |
334,184
-1,585
| -0.5% | -$168K |
|
182
HCA Healthcare
HCA
$91.8B
| $34.8M | 0.14% |
235,260
+92,179
| +64% | +$12.4M |
|
|
AXDX
183
DELISTED
Accelerate Diagnostics
AXDX
| $34.5M | 0.14% |
204,284
+25,041
| +14% | +$4.13M |
|
184
Netflix
NFLX
$325B
| $34M | 0.14% |
1,051,810
+69,900
| +7% | +$2.07M |
|
185
Truist Financial
TFC
$61.7B
| $34M | 0.14% |
604,255
+221,557
| +58% | +$12M |
|
186
Extra Space Storage
EXR
$29B
| $33.9M | 0.14% |
321,330
-20,981
| -6% | -$2.29M |
|
187
Simon Property Group
SPG
$66B
| $33.7M | 0.14% |
226,031
-42,991
| -16% | -$6.45M |
|
188
Consolidated Edison
ED
$38.9B
| $33.7M | 0.14% |
371,999
-139,802
| -27% | -$12.5M |
|
189
Alcon
ALC
$32.8B
| $33.6M | 0.14% |
594,070
+1,195
| +0.2% | +$68.4K |
|
190
Kimberly-Clark
KMB
$32.8B
| $33.4M | 0.14% |
243,001
+6,757
| +3% | +$914K |
|
191
CVS Health
CVS
$121B
| $33.2M | 0.13% |
446,430
-9,240
| -2% | -$649K |
|
192
FIVE9
FIVN
$2.47B
| $33.1M | 0.13% |
504,846
+40,259
| +9% | +$2.46M |
|
193
Wolfspeed
WOLF
$1.25B
| $33M | 0.13% |
714,416
+522,557
| +272% | +$24.4M |
|
194
American Water Works
AWK
$27.4B
| $32.9M | 0.13% |
267,778
+6,858
| +3% | +$831K |
|
|
AGN
195
DELISTED
Allergan plc
AGN
| $32.7M | 0.13% |
170,797
-3,178
| -2% | -$573K |
|
196
Quest Diagnostics
DGX
$27.3B
| $32.5M | 0.13% |
304,771
+130,224
| +75% | +$13.6M |
|
|
B
197
Barrick Mining
B
$70.3B
| $32.4M | 0.13% |
1,744,632
-11,526
| -0.7% | -$198K |
|
198
AbbVie
ABBV
$465B
| $32.3M | 0.13% |
364,947
-281,663
| -44% | -$23.4M |
|
199
BioMarin Pharmaceuticals
BMRN
$12.5B
| $32.2M | 0.13% |
381,366
-5,878
| -2% | -$444K |
|
200
Air Products & Chemicals
APD
$64.7B
| $31.9M | 0.13% |
135,699
-11,230
| -8% | -$2.53M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q4 2019 Portfolio in Review
As of Q4 2019, Axa held 1,387 positions worth $24.6B, down 2.1% from $25.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Axa withdrew a net $2.74B in Q4 2019, closing 225 positions and reducing 465 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $160M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Baker Hughes worth $26.1M.
- Axa's largest Q4 2019 buy was Baker Hughes: 1,017,347 shares worth $26.1M.
- Axa added most to Pfizer in Q4 2019, an estimated $66.4M increase.
- Axa's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $89.1M.
- Axa fully exited iShares Russell 1000 Growth ETF in Q4 2019, selling an estimated $160M.
- Axa's ten largest holdings make up 17% of its $24.6B portfolio in Q4 2019.
- Axa opened 97 new positions and closed 225 in Q4 2019.
- Axa's portfolio value fell 2.1% quarter-over-quarter to $24.6B.
Based on Axa's 13F filing for Q4 2019, filed 18 Feb 2020.